Skip to content

Clinical Trial of Chinese Medicine in the Treatment of Cough Variant Asthma

Clinical trial for Shufeng Wenfei Zhike granule in the Treatment of Cough Variant Asthma

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000029686
Enrollment
Unknown
Registered
2020-02-09
Start date
2020-02-29
Completion date
Unknown
Last updated
2022-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cough variant asthma

Interventions

Sponsors

Oriental Hospital of Beijing University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.The clinical diagnosis was CVA; 2.The syndrome differentiation of traditional Chinese medicine is cold fluid lurking in lung; 3.Aged 18-65 years; 4.Voluntary participation in the clinical trial, informed consent and signing of informed consent.

Exclusion criteria

Exclusion criteria: 1.Chronic cough caused by other causes 2.ALT, AST > upper limit of normal reference value 1.5 times or SCR > upper limit of normal reference value; 3.Have a long history of alcohol or drug abuse; 4.There are serious cardiovascular and cerebrovascular diseases; 5.Have mental or mental disorders; 6.Pregnant and lactating women; 7.Have a history of allergy to test drug ingredients; 8.The researchers think it is not suitable to participate in this clinical trial.

Design outcomes

Primary

MeasureTime frame
Cough symptom score;TCM symptom score;

Secondary

MeasureTime frame
Cough VAS score;Chinese LCQ score;

Countries

China

Contacts

Public ContactYang Kai

Oriental Hospital of Beijing University of Traditional Chinese Medicine

641179500@qq.com+86 15116992746

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026